|
| EPSRC Reference: |
EP/G039933/1 |
| Title: |
RCUK-DST India Science Bridge BioPharm 2020: Entrepreneurial Opportunities for Indian/UK Scientists in the Pharmaceutical and Biotechnology Industries |
| Principal Investigator: |
Professor K Shakesheff |
| Other Investigators: |
|
| Researcher Co-investigator: |
|
| Project Partner: |
| Indian Institute of Management Bangalore |
Indian Institute of Technology |
|
|
| Department: |
Sch of Pharmacy |
| Organisation: |
University of Nottingham |
| Scheme: |
Standard Research |
| Starts: |
20 April 2009 |
Ends: |
19 April 2012 |
Value (£): |
743,489
|
| EPSRC Research Topic Classifications: |
| Drug Formulation and Delivery |
|
|
| EPSRC Industrial Sector Classifications: |
|
| Related Grants: |
|
| Panel History: |
| Panel Date | Panel Name | Outcome |
|
10 Nov 2008
|
RCUK Science Bridges Awards
|
Announced
|
|
|
Summary |
The UK Pharmaceutical Industry generates annual exports of over 14 billion and an annual output per employee of 235,278 (ABPI 2006). A strong foundation for this industry is the investment in research and development (over 26% of gross output was re-invested in 2006) and innovation and knowledge transfer between Universities and Industry. The Indian Pharmaceutical and Biotechnology sectors are undergoing a dramatic evolution due to the adoption from January 2005 of the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) resulting in the recognition of product patents for pharmaceuticals. Growth rates for Indian Pharmaceutical Industries has accelerated from 9.5% to 13.6% since 2005 (Associated Chambers of Commerce India) and biotechnology growth rates exceed 37% (Biospectrum). However, several factors continue to shackle growth in India: absence of synergy between industry and academia, weak intellectual property (IP) portfolios, and insufficient knowledge transfer for commercialization being some of the key impediments. Thus, India is not realizing its potential in the Biotechnology and Pharmaceutical sectors, unlike the IT sector, for instance
Our BioPharm 2020 Science Bridge will exploit synergies between scientists and industries in India and the UK to create a step-change in collaborative innovation in target identification, drug discovery, drug delivery and manufacturing. The University of Nottingham (UoN), Indian Institute of Technology Kanpur (IITK) and Indian Institute of Management Bangalore (IIMB) will build on extensive collaborations with the goals of producing (a) clinical and commercial benefits from patent protected research, (b) world class human resource with a focus on interfing with Industry, and (c) to assess the supply chain and outsourcing potential for long term business engagement and policy formulation between the two countries.
BioPharm 2020 will deliver patent disclosures for inventions that are possible only due to the synergistic research expertises across the Science Bridge, a substantial cohort of students and early stage career academics with hands-on experience of innovation and long-term bonds between UK and Indian companies that exploit unique capabilities in each country.
|
| Final Report Summary |
|
No final report summary is available for this grant.
|
| Further Information: |
|
| Organisation Website: |
http://www.nott.ac.uk |
|
|